Variant report
Variant | nsv964354 |
---|---|
Chromosome Location | chr2:212500329-212503319 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529744373 | chr2:212500375-212500376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368962078 | chr2:212500376-212500377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147230525 | chr2:212500402-212500403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367978003 | chr2:212500405-212500406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560124101 | chr2:212500447-212500448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528677274 | chr2:212500469-212500470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577766239 | chr2:212500541-212500542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536561488 | chr2:212500583-212500584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374070191 | chr2:212500619-212500620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547766797 | chr2:212500723-212500724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571736748 | chr2:212500730-212500731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530910779 | chr2:212500768-212500769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138402372 | chr2:212500779-212500780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6706867 | chr2:212500790-212500791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs67127866 | chr2:212500826-212500827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546121292 | chr2:212500834-212500835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs202176757 | chr2:212500835-212500836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551101500 | chr2:212500836-212500837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28494172 | chr2:212500840-212500841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6722280 | chr2:212500841-212500842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575014872 | chr2:212500842-212500843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546465880 | chr2:212500847-212500848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566449669 | chr2:212500856-212500857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538408664 | chr2:212500904-212500905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10203821 | chr2:212500945-212500946 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs574950422 | chr2:212501085-212501086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537544711 | chr2:212501094-212501095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554691568 | chr2:212501108-212501109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189331323 | chr2:212501140-212501141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142782383 | chr2:212501158-212501159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560062037 | chr2:212501265-212501266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181671326 | chr2:212501325-212501326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75216508 | chr2:212501363-212501364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371980004 | chr2:212501370-212501371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561308546 | chr2:212501371-212501372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531175404 | chr2:212501413-212501414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572089138 | chr2:212501491-212501492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148761172 | chr2:212501555-212501556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561460575 | chr2:212501575-212501576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530011962 | chr2:212501593-212501594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546602958 | chr2:212501597-212501598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528411691 | chr2:212501653-212501654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75803511 | chr2:212501659-212501660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546876614 | chr2:212501694-212501695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7576417 | chr2:212501712-212501713 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs147411201 | chr2:212501758-212501759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73988624 | chr2:212501771-212501772 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs377586105 | chr2:212501780-212501781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554347173 | chr2:212501782-212501783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574498038 | chr2:212501798-212501799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212467400-212546800 | Weak transcription | Aorta | Aorta |
2 | chr2:212488400-212502800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:212502600-212503400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:212502800-212503600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |